Browse 1,565 thyroid cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Most thyroid cancers grow slowly and have some of the best outcomes of any cancer, which is why some small ones can now be safely monitored instead of removed right away. A small share behave very differently: cancers that stop responding to radioactive iodine, inherited medullary thyroid cancer, and the rare but aggressive anaplastic type. Targeted medicines matched to specific gene changes have opened new options for these groups.
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
for
Neoplasms
Location: New York NY, Montreal, Toronto, Pittsburgh PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 18+
Code: NCT06311578
Phase 1, Recruiting
Sample Collection and Tracking for the Developmental Therapeutics Clinic
for
Neoplasms, Lymphoma
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT03269578
Recruiting
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, Toronto, Ann Arbor MI, Houston TX, Dallas TX,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05941507
Phase 1, Phase 2, Recruiting
Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
for
Cancer
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT06475807
Recruiting
Emotion and Symptom-Focused Engagement (EASE) for Caregivers
for
Trauma and Stressor Related Disorders, Pediatric Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT06367556
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
for
Malignant Neoplasm of Bone and Articular Cartilage,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12 - 50
Code: NCT03093909
Phase 1, Recruiting
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
for
Solid Tumor, Adult, Oncology
Location: Huntersville NC, Santa Monica CA
Sponsor: Trethera
Sex: All
Age: 18+
Code: NCT05055609
Phase 1, Recruiting
Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
for
Cancer
Location: Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 18 - 70+
Code: NCT06246409
Recruiting
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
for
Cancer
Location: The Bronx NY, Scranton PA, Dickson City PA,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18+
Code: NCT06756607
Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Providence RI, New Haven CT, New York NY, Baltimore MD,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase 1, Phase 2, Recruiting
Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically
for
Dysphagia, Head and Neck Cancer
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT06192771
Recruiting
Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study)
for
Cancer, Older Adults
Location: Toronto
Sponsor: University of Toronto
Sex: All
Age: 70+
Code: NCT06464471
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
for
Solid Tumor
Location: New York NY, Tampa FL, Augusta GA, Chicago IL,
Sponsor: Eisai Inc.
Sex: All
Age: 18+
Code: NCT04300556
Phase 1, Phase 2, Recruiting
Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, Providence RI, New Haven CT,
Sponsor: Debiopharm International SA
Sex: All
Age: 12+
Code: NCT04855656
Phase 1, Recruiting
A Study of YL242 in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Sarasota FL, Grand Rapids MI, Nashville TN
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07197827
Phase 1, Phase 2, Recruiting
A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
for
Select Advanced Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06598371
Phase 1, Phase 2, Recruiting
Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
for
Advanced Malignant Solid Neoplasm,
Location: Columbus OH
Sponsor: Yuanquan Yang
Sex: All
Age: 18+
Code: NCT06470971
Phase 2, Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: Boston MA, Philadelphia PA, Fairfax VA, Detroit MI,
Sponsor: Frontier Medicines Corporation
Sex: All
Age: 18+
Code: NCT06244771
Phase 1, Phase 2, Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Philadelphia PA, Durham NC, Cincinnati OH, Nashville TN,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT03947385
Phase 1, Phase 2, Recruiting
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer